Immune Response Clinical Trials Keytruda Checkpoint Inhibitors T-cell Therapy Immune Checkpoints Vaccines CAR T Cell Therapy Treatment Methods Treatment Outcomes Resistance Mechanisms CAR-T Cell Therapy Tumor Immune Microenvironment Emotional Impact Immune Checkpoint Inhibition MDNA11 Dendritic Cells Age-related Cancer Patient Outcomes Treatment Options mRNA Technology Regulatory T Cells Chimeric Antigen Receptor Therapy Drug Development Tim Keller Natural Killer Cells Melanoma mRNA Vaccine Chemotherapy Vaccine Development Innovative Strategies Targeted Therapy mRNA Therapies Eosinophils Mitochondrial DNA Histotripsy Cytokine Signaling Research Research Studies Side Effects CAR T-Cell Therapy Peptide Identification Cellular Immunotherapy Radiotherapy CAR T Therapy Treatment Mental Health T Cells Fundraising Events
Want to see what podcasts are saying about this topic? Search across 130K+ podcasts. Explore Radar
A July 2026 Nature Communications paper shows researchers can curb myeloid-driven inflammation and restore T-cell tumor responses in aged animal models but clinical testing is required to confirm effects in people.
